Published Reported
FDA Reverses Course on Testosterone, Igniting a New Era for Men’s Health
The FDA has proposed removing the limitation of use for age-related low testosterone and narrowing the prostate cancer contraindication to metastatic disease, after removing the cardiovascular boxed warning language...